{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-06T07:21:41.329057+00:00","published_at":"2026-10-06T04:46:24.717656+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v1","events":[{"event_id":"alpha:event:gc_changed:1f24kmo","event_type":"GC_CHANGED","effective_at":"2026-04-27","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","alpha:person:christopher-w-gerry"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:d807ee1c42f379f5e7241867f5961d0503a0ecc0ce37ec66608aeebe9feaa46e"],"summary":"Christopher W. Gerry executive of Faeth Therapeutics, Inc., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:1k78pd8","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","alpha:person:kristian-humer-2"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"Kristian Humer seat on Faeth Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:mk5o0r","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","alpha:person:james-peyer"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"James Peyer seat on Faeth Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_created:w5rhdp","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:committee:faeth-therapeutics-inc:compensation-nominating-and-governance","alpha:company:59b43374-ca31-4533-861d-e1452e3887bf"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"Compensation; Nominating and Governance committee of Faeth Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_member_added:1qz2gge","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:committee:faeth-therapeutics-inc:compensation-nominating-and-governance","alpha:person:james-peyer"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"James Peyer member of Compensation; Nominating and Governance, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:1scxw59","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","alpha:person:john-celebi"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"John Celebi seat on Faeth Therapeutics, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:jbt9zv","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","alpha:person:bob-holmen"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"Bob Holmen seat on Faeth Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_created:1mqo92g","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:committee:faeth-therapeutics-inc:audit-compensation-chair","alpha:company:59b43374-ca31-4533-861d-e1452e3887bf"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"Audit; Compensation · Chair committee of Faeth Therapeutics, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_member_added:1achzu2","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:committee:faeth-therapeutics-inc:audit-compensation-chair","alpha:person:bob-holmen"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"Bob Holmen member of Audit; Compensation · Chair, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:director_appointed:1ymfxd3","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","alpha:person:thomas-ricks"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"Thomas Ricks seat on Faeth Therapeutics, Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_created:ozwuje","event_type":"COMMITTEE_CREATED","effective_at":"2015-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:committee:faeth-therapeutics-inc:audit-chair-compensation","alpha:company:59b43374-ca31-4533-861d-e1452e3887bf"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"Audit · Chair; Compensation committee of Faeth Therapeutics, Inc., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:committee_member_added:zw8vza","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2015-01-01","detected_at":"2026-10-06T04:46:24.717656+00:00","subject_ids":["alpha:committee:faeth-therapeutics-inc:audit-chair-compensation","alpha:person:thomas-ricks"],"caused_claim_ids":["alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781"],"summary":"Thomas Ricks member of Audit · Chair; Compensation, effective 2015-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:5","subject_id":"alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bob-holmen","object_label":"Bob Holmen","object_source_name_forms":[],"value":"Bob Holmen: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:bob-holmen","name":"Bob Holmen"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-06T04:46:24.717656+00:00","sources":[{"id":"alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Sensei Biotherapeutics, Inc. DEF 14A 2025-04-11","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","source_date":"2025-04-11","retrieved_at":"2026-04-28T23:56:01.279+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-11","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-06T04:46:24.717656+00:00","reviewed_at":"2026-10-06T04:46:24.717656+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:6","subject_id":"alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-peyer","object_label":"James Peyer","object_source_name_forms":[],"value":"James Peyer: Director, Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-peyer","name":"James Peyer"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-06T04:46:24.717656+00:00","sources":[{"id":"alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Sensei Biotherapeutics, Inc. DEF 14A 2025-04-11","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","source_date":"2025-04-11","retrieved_at":"2026-04-28T23:56:01.279+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-11","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-06T04:46:24.717656+00:00","reviewed_at":"2026-10-06T04:46:24.717656+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:7","subject_id":"alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-celebi","object_label":"John Celebi","object_source_name_forms":[],"value":"John Celebi: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-celebi","name":"John Celebi"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-06T04:46:24.717656+00:00","sources":[{"id":"alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Sensei Biotherapeutics, Inc. DEF 14A 2025-04-11","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","source_date":"2025-04-11","retrieved_at":"2026-04-28T23:56:01.279+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-11","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-06T04:46:24.717656+00:00","reviewed_at":"2026-10-06T04:46:24.717656+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:8","subject_id":"alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kristian-humer-2","object_label":"Kristian Humer","object_source_name_forms":[],"value":"Kristian Humer: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kristian-humer-2","name":"Kristian Humer"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-06T04:46:24.717656+00:00","sources":[{"id":"alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Sensei Biotherapeutics, Inc. DEF 14A 2025-04-11","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","source_date":"2025-04-11","retrieved_at":"2026-04-28T23:56:01.279+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-11","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-06T04:46:24.717656+00:00","reviewed_at":"2026-10-06T04:46:24.717656+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:9","subject_id":"alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:thomas-ricks","object_label":"Thomas Ricks","object_source_name_forms":[],"value":"Thomas Ricks: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:thomas-ricks","name":"Thomas Ricks"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-06T04:46:24.717656+00:00","sources":[{"id":"alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Sensei Biotherapeutics, Inc. DEF 14A 2025-04-11","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","source_date":"2025-04-11","retrieved_at":"2026-04-28T23:56:01.279+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-11","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-06T04:46:24.717656+00:00","reviewed_at":"2026-10-06T04:46:24.717656+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:59b43374-ca31-4533-861d-e1452e3887bf:leadership_role:11","subject_id":"alpha:company:59b43374-ca31-4533-861d-e1452e3887bf","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christopher-w-gerry","object_label":"Christopher W. Gerry","object_source_name_forms":[],"value":"Christopher W. Gerry: President, General Counsel and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christopher-w-gerry","name":"Christopher W. Gerry"},"title":"President, General Counsel and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-06T04:46:24.717656+00:00","sources":[{"id":"alpha:projection-evidence:document:d807ee1c42f379f5e7241867f5961d0503a0ecc0ce37ec66608aeebe9feaa46e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SNSE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000119312526182143/d16802ddef14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T08:28:22.444537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-06T04:46:24.717656+00:00","reviewed_at":"2026-10-06T04:46:24.717656+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:cc4d4be88d3e2523b78e89306d92c8e76885197673a18d769afce89e649b3781","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Sensei Biotherapeutics, Inc. DEF 14A 2025-04-11","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000095017025053033/snse-def-proxy-fy2024_no.htm","source_date":"2025-04-11","retrieved_at":"2026-04-28T23:56:01.279+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d807ee1c42f379f5e7241867f5961d0503a0ecc0ce37ec66608aeebe9feaa46e","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SNSE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000119312526182143/d16802ddef14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-16T08:28:22.444537+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.827,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.887,"cross_source_agreement":0.75,"temporal_completeness":0.375},"diagnostics":{"published_claims":23,"factual_claims":23,"claims_with_linked_evidence":23,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":16,"temporal_claims_with_valid_from":6,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-06T04:46:24.717656+00:00","observed_at":"2026-10-06T04:46:24.717656+00:00","reviewed_at":"2026-10-06T04:46:24.717656+00:00","verified_at":"2026-10-06T04:46:24.717656+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/faeth-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/faeth-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}